Calr plus Myelofibrosis/BCR-ABL Chronic Myeloid Leukemia Overlap Syndrome Treated with Asciminib

被引:0
|
作者
Saal, Talia M. [1 ]
Pellegrino, Christine [2 ]
Ahmed, Tauseef [2 ]
Seiter, Karen [3 ]
Liu, Delong [2 ]
Steinberg, Amir [2 ]
机构
[1] New York Med Coll, Valhalla, NY 10595 USA
[2] Westchester Med Ctr, Valhalla, NY USA
[3] Westchester Med Ctr, Larchmont, NY USA
关键词
D O I
10.1182/blood-2023-184820
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Identification of natural inhibitors of Bcr-Abl for the treatment of chronic myeloid leukemia
    Parcha, Phanikrishna
    Sarvagalla, Sailu
    Madhuri, Bindu
    Pajaniradje, Sankar
    Baskaran, Vinitha
    Coumar, Mohane Selvaraj
    Rajasekaran, Baskaran
    CHEMICAL BIOLOGY & DRUG DESIGN, 2017, 90 (04) : 596 - 608
  • [32] Characteristics of BCR-ABL gene variants in patients of chronic myeloid leukemia
    Amin, Huma
    Ahmed, Suhaib
    OPEN MEDICINE, 2021, 16 (01): : 904 - 912
  • [34] Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
    Goldman, JM
    Melo, JV
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14): : 1084 - 1086
  • [35] BCR-ABL independent gene mutations in patients with chronic myeloid leukemia
    Schmidt, M.
    Rinke, J.
    Schaefer, V.
    Ziermann, J.
    Eigendorff, E.
    Hochhaus, A.
    Ernst, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 210 - 210
  • [36] Imatinib mesylate, a selective inhibitor of BCR-ABL, in chronic myeloid leukemia
    Carella, Angelo Michele
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (03) : 249 - 251
  • [37] Chronic myeloid leukemia, BCR-ABL1-positive with CALR and MPL mutations
    Klairmont, M. M.
    Cheng, J.
    Schwartzberg, L.
    Ho, H. H.
    Gradowski, J. F.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 (03) : E41 - E42
  • [38] The role of Bcr-Abl in chronic myeloid leukemia and stem cell biology
    Witte, O
    SEMINARS IN HEMATOLOGY, 2001, 38 (03) : 3 - 8
  • [39] Frequency and Clonality of BCR-ABL Compound Mutations in Chronic Myeloid Leukemia
    Khorashad, Jamshid
    Kelley, Todd W.
    Szankasi, Philippe
    Adrian, Lauren T.
    Eide, Christopher A.
    Zabriskie, Matthew S.
    Lange, Thoralf
    Kraft, Ira L.
    Eiring, Anna M.
    O'Hare, Thomas
    Deininger, Michael W.
    BLOOD, 2011, 118 (21) : 1598 - 1599
  • [40] BCR-ABL/ABL RATIO INCREASE THAT CORRESPONDS TOPRESENCEOFBCR-ABL MUTATION IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED BY IMATINIB
    Tsaur, G.
    Ivanova, A.
    Popov, A.
    Yakovleva, Y.
    Riger, T.
    Ivanets, Y.
    Misyurin, A.
    Suchkova, M.
    Shorikov, E.
    Saveliev, L.
    Fechina, L.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S490 - S490